Join co-chairs Carlos L. Arteaga, M.D., Debb Farr, & @HMcArthur for the Wendy & Emery Reves International Breast Cancer Symposium May 3-4 with keynote speakers Dr. E Mittendorf & MassagueLab for updates on the latest in research & clinical care. #UTSW

Register: bit.ly/42owfhm

10 days until the 2024 Reves International Breast Cancer Symposium!

Featuring a Keynote lecture by Dr. Joan Massague (MassagueLab)

Register today: events.utsouthwestern.edu/event/wendy_em…

UTSW Simmons Cancer Center
Carlos L. Arteaga, M.D.
Debb Farr
Memorial Sloan Kettering Cancer Center
#bcsm
#breastcancer

Hear from this panel of experts as they discuss recent data updates on the treatment and management of HER2+ #BreastCancer and how these data may impact practice. Joyce O'Shaughnessy, MD Claudine Isaacs Heather McArthur, MD, MPH Hope Rugo onclive.com/view/evolving-…

COUNTDOWN TO THE 2024 REVES BREAST CANCER SYMPOSIUM:

15 DAYS…Featuring a Keynote lecture by Dr. Elizabeth Mittendorf (Dr. E Mittendorf) on Breast Cancer Immunotherapy: Past, Present and Future

Register today: events.utsouthwestern.edu/event/wendy_em…

UTSW Simmons Cancer Center
Carlos L. Arteaga, M.D.
Debb Farr
#bcsm

Adding checkpoint inhibition immunotherapy to adjuvant #chemotherapy did not improve survival among patients with triple-negative #breastcancer , according to a new study. Heather McArthur, MD, MPH, discusses the results in this #podcast : ow.ly/6k5s50Rfo0F Heather McArthur, MD, MPH

View our top 5 posts from last week:
SGO Alison Schram European Breast Cancer Conference (EBCC-14) Heather McArthur, MD, MPH
EU Medicines Agency Lung Cancer Europe
Rian M. Hasson Charles, MD, MPH, FACS (She/Her)

1. cancernetwork.com/view/rezatapop…

2. cancernetwork.com/view/adjuvant-…

3. cancernetwork.com/view/eu-s-chmp…

4. cancernetwork.com/view/osimertin…

5. cancernetwork.com/view/forging-a…

Heather McArthur, MD, MPH, on Early-Stage High-Risk ER+/HER2− Breast Cancer: New pCR Results for Pembrolizumab and Chemotherapy ascopost.com/videos/2024-so… #bcsm #breastcancer #SSO2024 #SSO24 Society of Surgical Oncology Heather McArthur, MD, MPH UTSW Simmons Cancer Center UT Southwestern Medical Center

WATCH: Heather McArthur, MD, MPH & VIRGINIA KAKLAMANI expand upon the SOC regimens used for 1st-line treatment of pts w/ HER2+ metastatic #BreastCancer , review data supporting their use, & share excitement for upcoming data readouts on novel regimens in the space. #bcsm onclive.com/view/standard-…

Following a monitoring period of 32 months, no clinical benefit was observed when atezolizumab was added to adjuvant chemotherapy for patients with TNBC, according to the phase 3 IMpassion030 trial. Heather McArthur, MD, MPH #oncology #MedTwitter #bcsm #TNBC #EBCC14 onclive.com/view/post-surg…

The addition of atezolizumab to post-surgery chemotherapy did not show a clinical benefit for patients with triple-negative breast cancer, according to results from the phase 3 ALEXANDRA/IMpassion030 trial. #bcsm #EBCC14 | Heather McArthur, MD, MPH European Breast Cancer Conference (EBCC-14)

cancernetwork.com/view/adjuvant-…

Thank you for the opportunity to present the #KEYNOTE756 data Society of Surgical Oncology! A potential future clinical practice change!! Stay tuned for the EFS update!! #SSO2024 #bcsm

The #OncoAlertTopTweet for DAY1⃣ #EBCC14
Tweet Heather McArthur, MD, MPH 🇺🇸

Final analysis of #IMpassion030 /ALEXANDRA

#EBCC14 Update from Heather McArthur, MD, MPH KN-756 Neoadjuvant pembro early-stage high-risk ER+ HER2- #bcsm

Just out Day1⃣ of #EBCC14 🇮🇹Milan

Tweet Dr. Jeff Cao
Update from Heather McArthur, MD, MPH KN-756 Neoadjuvant pembro early-stage high-risk ER+ HER2- #BreastCancer

Live DAY1⃣ #EBCC14 🚨

Tweet Dr. Jeff Cao
Heather McArthur, MD, MPH 🇺🇸with Final analysis of ALEXANDRA/ IMpassion030 Adjuvant atezolizumab🧪 for stage ll/III TNBC #BreastCancer

Excited to be presenting the final analysis of #IMpassion030 /ALEXANDRA at #EBCC14 in Milan today!! An important #TNBC study and a tremendous collaboration!!

Thank you LACOG - Latin American Cooperative Oncology Group for the tremendous hospitality in Sao Paulo and congratulations on another outstanding #breastcancer program!!! #bcsm

Best speaker ready room EVER #MBCC2024 Komal Jhaveri Heather McArthur, MD, MPH